FONTANA, Calif.--(BUSINESS WIRE)--April 17, 2006--GEN ID Lab Services, Inc. (“GEN ID”) (OTC:GDLB - News) today announced that the company will be conducting research in the area of antiviral compounds to identify molecules to treat human infections with the Avian Flu Virus (H5N1) or a mutant version thereof. This is a rapid line of defense in the event that a vaccine is not ready or cannot be manufactured quickly enough for combating an outbreak of the disease, should it occur.
